Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT04074135
Eligibility Criteria:
* INCLUSION CRITIERIA:
1. Participants who have been diagnosed with VHL using the following criteria:
\-- Identification of a heterozygous germline pathogenic variant in VHL by molecular genetic testing.
or
\-- Clinical criteria
2. Participants with at least 1 pancreatic manifestation of VHL as documented on any non-invasive imaging study. These manifestations may include:
* Pancreatic cyst(s)
* Solid lesions suspicious for microcystic adenoma(s)
* Solid enhancing lesions suspicious for PNET(s)
* Any other solid lesion(s) of the pancreas
3. Age greater than or equal to 12 years.
4. Ability of participant to understand and the willingness to sign a written informed consent document.
EXCLUSION CRITERIA:
1\. Inability of participant to undergo serial non-invasive imaging.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT04074135
Study Brief:
Protocol Section:
NCT04074135